- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | SeaStar Medical Holding Corporation: SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure | 1 | GlobeNewswire (USA) | ||
| Fr | SeaStar Medical Holding Corp - 10-K/A, Annual Report | 2 | SEC Filings | ||
| 17.04. | SeaStar Medical Holding GAAP EPS of -$1.21 misses by $0.60 | 4 | Seeking Alpha | ||
| 17.04. | SeaStar Medical Holding Corporation: SeaStar Medical Reports 2023 Financial Results and Provides a Business Update | 529 | GlobeNewswire (Europe) | DENVER, April 17, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary... ► Artikel lesen | |
| 17.04. | SeaStar Medical Holding Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 17.04. | SeaStar Medical Holding Corp reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 16.04. | SeaStar Medical Holding Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| 11.04. | SeaStar Medical Holding Corporation: SeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference | 2 | GlobeNewswire (USA) | ||
| 08.04. | Peering Into SeaStar Medical Holding's Recent Short Interest | 3 | Benzinga.com | ||
| 01.04. | SeaStar Medical Holding Corp - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 27.03. | SeaStar Medical Holding Corporation: SeaStar Medical to Restate Financials, Sets Business Update Call for April 17 | 2 | GlobeNewswire (USA) | ||
| 27.03. | SeaStar Medical Holding Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 27.03. | SeaStar Medical Holding Corp expected to post a loss of 13 cents a share - Earnings Preview | 1 | Reuters | ||
| 11.03. | SeaStar Medical Holding Corporation: SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024 | 1 | GlobeNewswire (USA) | ||
| 08.03. | SeaStar Medical Holding Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 04.03. | Peering Into SeaStar Medical Holding's Recent Short Interest | 1 | Benzinga.com | ||
| 22.02. | SeaStar's Quelimmune Pediatric Device Gets Humanitarian Device Exemption From FDA; Stock Down | 4 | RTTNews | ||
| 22.02. | SeaStar up on FDA's humanitarian exception approval for kidney device | 1 | Reuters | ||
| 22.02. | SeaStar receives FDA approval for first Quelimmune device for pediatric AKI | 2 | Investing.com | ||
| 22.02. | Nuwellis, Inc.: Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune | 215 | GlobeNewswire (Europe) | MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its distribution... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 36,980 | -0,64 % | Aktien KW 17 war's das mit der Konsolidierung? Kamen Freitag die Bullen zurück? Ballard Power. Endor. Encavis. USU Software. SFC Energy. flatexDEGIRO. Hamborner. Surteco. Netflix. Eckert&Ziegler. Intershop. Kion | Aktien Wochenrückblick - Konsolidierung? Zumindest ging es rückwärts, nicht zu stark, aber die Vorsicht übernahm das Ruder. Nicht mehr Buy the Dip, sondern Gewinne realisieren, auf fallende Kurse setzen.... ► Artikel lesen | |
| ROKU | 54,64 | +1,19 % | Roku: Wachstum beschleunigt sich, Verluste weiter reduziert | SAN JOSE, Kalifornien (IT-Times) - Roku, Anbieter von Hard- und Software für Video-Streaming-Services, hat seine Ergebnisse für das Auftaktquartal 2024 veröffentlicht und ein zweistelliges Wachstum... ► Artikel lesen | |
| ORPEA | 13,000 | +2,04 % | ORPEA: emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million | Regulatory News:
ORPEA (Paris:ORP):
emeis announces that it has signed an agreement to sell a real estate portfolio of eleven nursing homes in the Netherlands to Bouwinvest for a total deed-in-hand... ► Artikel lesen | |
| NANO-X IMAGING | 9,230 | +0,87 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,590 | 0,00 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-a-NET in NETs | SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,887 | +8,94 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 6,890 | -1,29 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,710 | -0,78 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
| CARMAT | 2,900 | -3,33 % | CARMAT: Availability of the 2023 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| PROGYNY | 31,840 | -1,36 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| HYPERFINE | 0,780 | -1,27 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| BIOMERICA | 0,615 | -2,40 % | Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company | ||
| MIMEDX | 7,500 | +2,74 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| ATRICURE | 22,280 | -10,20 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| ATRION | 396,00 | +1,54 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen |
SEASTAR MEDICAL HOLDING CORPORATION gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,495 Euro und damit +7,54 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
